Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Support
Write for Us
Media Info
Advertising Info
Mistletoe extract

Mistletoe extract doubles survival time of pancreatic cancer patients in clinical trial

Tuesday, October 22, 2013 by: Ethan Evers
Tags: mistletoe extract, pancreatic cancer, survival time

Most Viewed Articles
https://www.naturalnews.com/042609_mistletoe_extract_pancreatic_cancer_survival_time.html
Delicious
diaspora
Print
Email
Share

(NaturalNews) Patients with locally advanced or metastatic pancreatic cancer doubled their survival time when treated with mistletoe extract in a new European clinical trial - and with very few side effects. In comparison, the standard chemo drugs for treating pancreatic cancer carry such serious side effects that patients and their doctors often forgo chemotherapy and opt for best supportive care instead.

Pancreatic cancer strikes 44,000 Americans every year and is the fourth leading cause of cancer-related death in the USA. Despite conventional medicine's best efforts, the mortality rate of pancreatic cancer remains tragically high at 80 percent in the first years after diagnosis. Because of this, natural treatments may be a real option for improving patients' prognosis.

Survival time doubles for pancreatic cancer patients using mistletoe

This new Phase III clinical trial was randomized, open-label and carried out in Serbia on 220 patients. All patients received best supportive care. Patients in the treatment group also received subcutaneous injections of mistletoe extract three times weekly with dosages escalating from 0.01 mg up to a constant 10 mg after the 22nd dose. Patients who started the study with a 'good prognosis' saw their survival times more than double from 3.2 months (if untreated) to 6.6 months if treated with mistletoe. Likewise, patients with a 'poor prognosis' averaged 2.0 months survival if untreated but 3.4 months if treated with mistletoe. Remarkably, the group treated with mistletoe experienced only 16 adverse events compared to 53 adverse events in the untreated group. Rather than carrying negative side effects as chemo drugs do, the mistletoe treatment actually decreased the likelihood of painful or undesirable effects (adverse events) by 75 percent. And none of the adverse events in the mistletoe group were caused by the mistletoe itself.

This clinical trial achieved such impressive results that it was terminated early so that all the patients could receive the mistletoe extract, based on recommendations of the Independent Data Monitoring Committee.

Mistletoe is already successful in treating multiple cancers

This is not the first time that mistletoe has had success in treating cancer. Many observational and clinical trials carried out in Europe have already shown impressive results for treating cancer of the breast, uterus, cervix, ovaries, stomach, lung and colon, as well as melanoma. One large review carried out in Germany found that cancer patients extended their survival times by roughly 40 percent when mistletoe was added to their therapy (4.23 versus 3.05 years survival). A more recent meta-study (covering 49 trials) confirmed a survival benefit as well as a near universal improvement in quality-of-life.

Mistletoe still banned in the US: Is good science being ignored?

With all of this accumulating evidence in favor of mistletoe and decades of use in Europe, it is strange that it remains banned in the US by the FDA. Past trials have indeed shown inconsistent results, but we now know this is due to the varying quality of the different extracts used. The most favorable and consistent results (including the large studies quoted above and the new trial on pancreatic cancer) have been achieved with an extract made in Switzerland using mistletoe grown on oak trees. This particular extract appears to contain the best combination of active phytochemicals (lectins, viscotoxins, flavonoids, triterpene acids, etc.) and is now being used in two large European trials (400 patients with pancreatic cancer and 800 patients with colorectal cancer). Until American authorities accept mistletoe's safety and efficacy, it appears that the benefits of mistletoe will only be enjoyed by patients in European countries which are more advanced in the science of natural medicine.

Sources for this article include:

http://www.ncbi.nlm.nih.gov

http://www.naturalnews.com

http://www.ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov

http://science.naturalnews.com

About the author:
Ethan Evers is author of the award-winning medical thriller "The Eden Prescription," in which cutting-edge researchers perfect an effective, all-natural treatment for cancer, only to be hunted down by pharmaceutical interests which will stop at nothing to protect their $80 billion cancer drug cash machine. The Eden Prescription is based on the latest science and draws on real historical events stretching back to the beginning of the "War on Cancer." Ethan has a PhD in Applied Science.

The Eden Prescription is available on amazon: www.amazon.com/Eden-Prescription-cancer-what...
Follow Ethan on Facebook for the latest breakthroughs and news on natural medicine for cancer: www.facebook.com/pages/The-Eden-Prescription...
For more information: www.edenprescription.com





Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus



Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more